Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Anti-Malarial Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.8% during the forecast period.
This report presents the market size and development trends by detailing the Anti-Malarial Drug market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Anti-Malarial Drug market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Anti-Malarial Drug industry and will help you to build a panoramic view of the industrial development.
Anti-Malarial Drug Market, By Type:
Plasmodium Falciparum
Plasmodium Vivax
Plasmodium Malariae
Plasmodium Ovale
Anti-Malarial Drug Market, By Application:
Hospital Pharmacy
Retail Pharmacy
E-Commerce
Others
Some of the leading players are as follows:
Novartis
Ipca
Pfizer
Bayer
F Hoffmann-La Roche
F. Hoffmann-La Roche
Zydus Cadila
Ranbaxy
Merck
GlaxoSmithKline
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Anti-Malarial Drug Market: Technology Type Analysis
-
4.1 Anti-Malarial Drug Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Anti-Malarial Drug Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Plasmodium Falciparum
4.3.2 Plasmodium Vivax
4.3.3 Plasmodium Malariae
4.3.4 Plasmodium Ovale
5 Anti-Malarial Drug Market: Product Analysis
-
5.1 Anti-Malarial Drug Product Market Share Analysis, 2018 & 2026
-
5.2 Anti-Malarial Drug Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Anti-Malarial Drug Market: Application Analysis
-
6.1 Anti-Malarial Drug Application Market Share Analysis, 2018 & 2026
-
6.2 Anti-Malarial Drug Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Hospital Pharmacy
6.3.2 Retail Pharmacy
6.3.3 E-Commerce
6.3.4 Others
7 Anti-Malarial Drug Market: Regional Analysis
-
7.1 Anti-Malarial Drug Regional Market Share Analysis, 2018 & 2026
-
7.2 Anti-Malarial Drug Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Novartis
9.1.1 Novartis Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Ipca
9.2.1 Ipca Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Pfizer
9.3.1 Pfizer Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Bayer
9.4.1 Bayer Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 F Hoffmann-La Roche
9.5.1 F Hoffmann-La Roche Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 F. Hoffmann-La Roche
9.6.1 F. Hoffmann-La Roche Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Zydus Cadila
9.7.1 Zydus Cadila Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Ranbaxy
9.8.1 Ranbaxy Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Merck
9.9.1 Merck Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 GlaxoSmithKline
9.10.1 GlaxoSmithKline Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 90 Figures and 140 Tables)
Figure Plasmodium Falciparum Anti-Malarial Drug market, 2015 - 2026 (USD Million)
Figure Plasmodium Vivax Anti-Malarial Drug market, 2015 - 2026 (USD Million)
Figure Plasmodium Malariae Anti-Malarial Drug market, 2015 - 2026 (USD Million)
Figure Plasmodium Ovale Anti-Malarial Drug market, 2015 - 2026 (USD Million)
Figure Hospital Pharmacy market, 2015 - 2026 (USD Million)
Figure Retail Pharmacy market, 2015 - 2026 (USD Million)
Figure E-Commerce market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Anti-Malarial Drug market, by country, 2015 - 2026 (USD Million)
-
Table North America Anti-Malarial Drug market, by type, 2015 - 2026 (USD Million)
-
Table North America Anti-Malarial Drug market, by product, 2015 - 2026 (USD Million)
-
Table North America Anti-Malarial Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Anti-Malarial Drug market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Anti-Malarial Drug market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Anti-Malarial Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Anti-Malarial Drug market, by type, 2015 - 2026 (USD Million)
-
Table Canada Anti-Malarial Drug market, by product, 2015 - 2026 (USD Million)
-
Table Canada Anti-Malarial Drug market, by application, 2015 - 2026 (USD Million)
-
Table Europe Anti-Malarial Drug market, by country, 2015 - 2026 (USD Million)
-
Table Europe Anti-Malarial Drug market, by type, 2015 - 2026 (USD Million)
-
Table Europe Anti-Malarial Drug market, by product, 2015 - 2026 (USD Million)
-
Table Europe Anti-Malarial Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Anti-Malarial Drug market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Anti-Malarial Drug market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Anti-Malarial Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Anti-Malarial Drug market, by type, 2015 - 2026 (USD Million)
-
Table Germany Anti-Malarial Drug market, by product, 2015 - 2026 (USD Million)
-
Table Germany Anti-Malarial Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Anti-Malarial Drug market, by type, 2015 - 2026 (USD Million)
-
Table France Anti-Malarial Drug market, by product, 2015 - 2026 (USD Million)
-
Table France Anti-Malarial Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Anti-Malarial Drug market, by type, 2015 - 2026 (USD Million)
-
Table Italy Anti-Malarial Drug market, by product, 2015 - 2026 (USD Million)
-
Table Italy Anti-Malarial Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Anti-Malarial Drug market, by type, 2015 - 2026 (USD Million)
-
Table Spain Anti-Malarial Drug market, by product, 2015 - 2026 (USD Million)
-
Table Spain Anti-Malarial Drug market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Anti-Malarial Drug market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Anti-Malarial Drug market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Anti-Malarial Drug market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Anti-Malarial Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Anti-Malarial Drug market, by type, 2015 - 2026 (USD Million)
-
Table China Anti-Malarial Drug market, by product, 2015 - 2026 (USD Million)
-
Table China Anti-Malarial Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Anti-Malarial Drug market, by type, 2015 - 2026 (USD Million)
-
Table Japan Anti-Malarial Drug market, by product, 2015 - 2026 (USD Million)
-
Table Japan Anti-Malarial Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Anti-Malarial Drug market, by type, 2015 - 2026 (USD Million)
-
Table India Anti-Malarial Drug market, by product, 2015 - 2026 (USD Million)
-
Table India Anti-Malarial Drug market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Anti-Malarial Drug market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Anti-Malarial Drug market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Anti-Malarial Drug market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Anti-Malarial Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Anti-Malarial Drug market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Anti-Malarial Drug market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Anti-Malarial Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Anti-Malarial Drug market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Anti-Malarial Drug market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Anti-Malarial Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Anti-Malarial Drug market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Anti-Malarial Drug market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Anti-Malarial Drug market, by application, 2015 - 2026 (USD Million)
-
Table MEA Anti-Malarial Drug market, by country, 2015 - 2026 (USD Million)
-
Table MEA Anti-Malarial Drug market, by type, 2015 - 2026 (USD Million)
-
Table MEA Anti-Malarial Drug market, by product, 2015 - 2026 (USD Million)
-
Table MEA Anti-Malarial Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Anti-Malarial Drug market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Anti-Malarial Drug market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Anti-Malarial Drug market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Anti-Malarial Drug market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Anti-Malarial Drug market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Anti-Malarial Drug market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Novartis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Ipca Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bayer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table F Hoffmann-La Roche Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table F. Hoffmann-La Roche Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Zydus Cadila Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Ranbaxy Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
